CMS seeks input for rule to mandate e-prescribing of controlled substances
The Centers for Medicare & Medicaid Services seeks input on rulemaking to require electronic prescribing for controlled substances covered by Medicare Part D and Medicare Advantage prescription drug plans beginning Jan. 1, in accordance with the Substance Use-Disorder Prevention that Promotes Opioid Recover and Treatment for Patients and Communities Act of 2018.
The request for information asks whether there should be exceptions to the requirement and under what circumstances, and whether CMS should impose penalties for noncompliance. Comments are due Oct. 3.
Related News Articles
Headline
The House Ways and Means Committee July 1 voted along party lines to advance a bill, H.R. 9504, the Tax-Exempt Hospitals Transparency Act, that would add…
Headline
The Department of Health and Human Services published an interim final rule May 7 to delay compliance dates for entities receiving federal financial assistance…
Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Headline
The Department of Justice April 20 published an interim final rule in the Federal Register to delay compliance dates for certain regulatory requirements…
Headline
The AHA today responded to a Centers for Medicare & Medicaid Services request for information on its Comprehensive Regulations to Uncover Suspicious…
Headline
The Department of Health and Human Services March 20 released a final rule establishing a standard format for attachments to support electronic health care…